We then evaluated whether donepezil, which improves cognitive decline in patients with DLB and PDD,51, 52 can reverse the memory deficits observed in the CaMKIIα‐tTA/A53T α‐syn dTg mice. This evidence concerns the gene CAMK2A and Lewy body dementia.